Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: Protocol for a prospective cohort study

BMJ Open

Volumn 7, Issue 3, 2017, Pages

  Sindhu, Kuladaipalayam Natarajan C ^a   Cunliffe, Nigel ^b   Peak, Matthew ^c   Turner, Mark ^b   Darby, Alistair ^b   Grassly, Nicholas ^d   Gordon, Melita ^b   Dube, Queen ^e   Babji, Sudhir ^a   Praharaj, Ira ^a   Verghese, Valsan ^a   Iturriza Gómara, Miren ^b   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; MATERNAL ANTIBODY; ROTAVIRUS VACCINE; IMMUNOGLOBULIN A; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AFRICAN; ANTIBODY TITER; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; EUROPEAN; FEMALE; HIGHEST INCOME GROUP; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INDIAN; INFANT; INTESTINE FLORA; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MICROBIOME; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; SEROCONVERSION; THIRD TRIMESTER PREGNANCY; AFRICA; CLINICAL TRIAL; ENGLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; EUROPE; GASTROENTERITIS; IMMUNOLOGY; INDIA; MULTICENTER STUDY; PRESCHOOL CHILD;

AFRICA; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; DNA, VIRAL; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPE; FEMALE; GASTROENTERITIS; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INDIA; INFANT; PROSPECTIVE STUDIES; ROTAVIRUS VACCINES;

EID: 85016457379     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2017-016577     Document Type: Article

References (47)

1. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Int J Surg 2014;12:1495-9.
2. Walker CLF, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013;381:1405-16.
3. Liu L, Oza S, Hogan D, et al. Global, regional, national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: An updated systematic analysis. Lancet 2015;385:430-40.
4. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet 2013;382:209-22.
5. Platts-Mills JA, Babji S, Bodhidatta L, et al. Pathogen-specific burdens of community diarrhoea in developing countries: A multisite birth cohort study (MAL-ED). Lancet Glob Health 2015;3:e564-75.
6. Tate JE, Burton AH, Boschi-Pinto C, et al. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: A systematic review and meta-analysis. Lancet Infect Dis 2012;12:136-41.
7. Morris SK, Awasthi S, Khera A, et al. Rotavirus mortality in India: Estimates based on a nationally representative survey of diarrhoeal deaths. Bull World Health Organ 2012;90:720-7.
8. John J, Sarkar R, Muliyil J, et al. Rotavirus gastroenteritis in India, 2011-2013: Revised estimates of disease burden and potential impact of vaccines. Vaccine 2014;32(Suppl 1):A5-9.
9. Tate JE, Patel MM, Cortese MM, et al. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Rev Vaccines 2012;11:211-20.
10. Levine MM. Immunogenicity and efficacy of oral vaccines in developing countries: Lessons from a live cholera vaccine. BMC Biol 2010;8:129.
11. Lopman BA, Pitzer VE, Sarkar R, et al. Understanding Reduced Rotavirus Vaccine Efficacy in Low Socio-Economic Settings. PLoS ONE 2012;7:e41720.
12. Gladstone BP, Ramani S, Mukhopadhya I, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med 2011;365:337-46.
13. Shin S, Anh DD, Zaman K, et al. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine 2012;30 (Suppl 1):A106-13.
14. Chan J, Nirwati H, Triasih R, et al. Maternal antibodies to rotavirus: Could they interfere with live rotavirus vaccines in developing countries Vaccine 2011;29:1242-7.
15. Appaiahgari MB, Glass R, Singh S, et al. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine 2014;32:651-6.
16. Moon S-S, Wang Y, Shane AL, et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J 2010;29:919-23.
17. Moro L, Bardají A, Nhampossa T, et al. Malaria and HIV infection in Mozambican pregnant women are associated with reduced transfer of antimalarial antibodies to their newborns. J Infect Dis 2015;211:1004-14.
18. LeBlanc JG, Milani C, de Giori GS, et al. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr Opin Biotechnol 2013;24:160-8.
19. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012;336: 1268-73.
20. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012;336:1262-7.
21. Atarashi K, Honda K. Microbiota in autoimmunity and tolerance. Curr Opin Immunol 2011;23:761-8.
22. Slack E, Hapfelmeier S, Stecher B, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 2009;325:617-20.
23. Subramanian S, Huq S, Yatsunenko T, et al. Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 2014;510:417-21.
24. Smith MI, Yatsunenko T, Manary MJ, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013;339:548-54.
25. Oh JZ, Ravindran R, Chassaing B, et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 2014;41:478-92.
26. Kuss SK, Best GT, Etheredge CA, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011;334:249-52.
27. Baldassarre ME, Bellantuono L, Mastromarino P, et al. Gut and Breast Milk Microbiota and Their Role in the Development of the Immune Function. Curr Pediatr Rep 2014;2:218-26.
28. Walker WA, Iyengar RS. Breast milk, microbiota, intestinal immune homeostasis. Pediatr Res 2015;77:220-8.
29. CountrySTAT Food and agriculture data network. http://www. countrystat.org/30. Data Portal Malawi. http://www.dataportal.nsomalawi.mw/31. Registrar General, India. Sample registration system. Estimated birth rate, death rate, natural growth rate and infant mortality rate, 2014. SRS Bulletin 2014;49:1-6.
30. National Child and Maternal Health Intelligence Network. Public Health England, Child Health Profile, Liverpool, June 2015. http://www.chimat.org.uk.
31. Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: A randomised, double-blind, placebo-controlled trial. Lancet 2014;383:2136-43.
32. Patel M, Shane AL, Parashar UD, et al. Oral rotavirus vaccines: How well will they work where they are needed most J Infect Dis 2009;200(Suppl 1):S39-48.
33. Cunliffe NA, Witte D, Ngwira BM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomised, double-blind, placebo controlled trial. Vaccine 2012; 30:A36-43.
34. Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine 2012;30(Suppl 1):A30-35.
35. Jog PP. Goodbye Switch and Imminent Polio Victory. Indian Pediatr 2016;53:285-8.
36. Meeting of the Strategic Advisory Group of Experts on immunization, November 2013-conclusions and recommendations. Wkly Epidemiol Rec 2014;89:1-20.
37. Kosek M, Haque R, Lima A, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg 2013;88:390-6.
38. Nikolenko SI, Korobeynikov AI, Alekseyev MA. BayesHammer: Bayesian clustering for error correction in single-cell sequencing. BMC Genomics 2013;14(Suppl 1):S7.
39. Zhang J, Kobert K, Flouri T, et al. PEAR: A fast and accurate Illumina Paired-End reAd mergeR. Bioinforma Oxf Engl 2014;30:614-20.
40. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010;7:335-6.
41. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinforma Oxf Engl 2010;26:2460-1.
42. Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinforma Oxf Engl 2011;27:2194-200.
43. Hodgins DC, Kang SY, de Arriba L, et al. Effects of Maternal Antibodies on Protection and Development of Antibody Responses to Human Rotavirus in Gnotobiotic Pigs. J Virol 1999;73:186-97.
44. Rongsen-Chandola T, Strand TA, Goyal N, et al. Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 2014;32(Suppl 1): A134-139.
45. Ali A, Kazi AM, Cortese MM, et al. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine-a randomized trial. PLoS ONE 2015;10: E0127622.
46. UNAIDS-The Gap Report-2015 Regional snapshots: Sub-Saharan Africa 2014; 40. http://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS-Gap-report-en.pdf.
47. Zaman K, Fleming JA, Victor JC, et al. Noninterference of rotavirus vaccine with measles-rubella vaccine at 9 months of age and improvements in antirotavirus immunity: A randomized trial. J Infect Dis 2016;213:1686-93.